ipriflavone has been researched along with Arthritis, Rheumatoid in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, M | 1 |
| Suzuki, K | 1 |
| Hidaka, T | 1 |
| Shinohara, T | 1 |
| Kataharada, K | 1 |
| Matsumoto, M | 1 |
| Takada, K | 1 |
| Ohsuzu, F | 1 |
1 other study available for ipriflavone and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Rapid improvement of osteomalacia by treatment in a case with Sjögren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1.
Topics: Acidosis, Renal Tubular; Adjuvants, Immunologic; Analgesics; Arthritis, Rheumatoid; Bone Density; Ca | 2001 |